Ann: Quarterly Activities Report - December 2018, page-7

My understanding was the previous R&D Grant was pro-rataed on the back on DiaSource Sale, so the next would be up to 2x that.  (is that correct Harry?)

This was interesting wording.
"Theintegration of the Anteo technologyinto PoC systems, similar to those being developed by partners such as Ellume, demonstrates the importance of the supporting role Anteo is playing by supplying valuable components that then enable superior performance of diagnostic systems."

Is 3rd party uptake on "Anteo tech enhanced" POCs, progressed a little further than previously noted?